Evaluation of a 99mTc-labeled cyclic RGD tetramer for noninvasive imaging integrin αvβ3-positive breast cancer

被引:130
作者
Liu, Shuang
Hsieh, Wen-Yuan
Jiang, Young
Kim, Young-Seung
Sreerama, Subramanya G.
Chen, Xiaoyuan
Jia, Bing
Wang, Fan
机构
[1] Purdue Univ, Sch Hlth Sci, W Lafayette, IN 47907 USA
[2] Stanford Univ, Dept Radiol & BioX, Mol Imaging Program Stanford, Stanford, CA 94305 USA
[3] Peking Univ, Med Isotopes Res Ctr, Beijing 100083, Peoples R China
关键词
D O I
10.1021/bc0603081
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Integrin alpha(v)beta(3) plays a critical role in tumor angiogenesis and metastasis. Radiolabeled RGD peptides that are integrin alpha(v)beta(3)-specific are very useful for noninvasive imaging of integrin expression in rapidly growing and metastatic tumors. In this study, we determined the binding affinity of E{E[c(RGDfK)](2)}(2) (tetramer) and its 6-hydrazinonicotinamide conjugate (HYNIC-tetramer) against the binding of I-125-echistatin to the integrin alpha(v)beta(3)-positive MDA-MB-435 breast cancer cells. The athymic nude mice bearing MDA-MB-435 xenografts were used to evaluate the potential of ternary ligand complex [Tc-99m(HYNIC-tetramer)(tricine)(TPPTS)] (TPPTS = trisodium triphenylphosphine-3,3',3' '-trisulfonate) as a new radiotracer for imaging breast cancer integrin alpha(v)beta(3) expression by single photon emission computed tomography (SPECT). It was found that the binding affinity of tetramer (IC50 = 51 +/- 11 nM) was slightly higher than that of its dimeric analogue (IC50 = 78 +/- 27 nM) and is comparable to that of the HYNIC-tetramer conjugate (IC50 = 55 +/- 11 nM) within the experimental error. Biodistribution data showed that [Tc-99m(HYNIC-tetramer)(tricine)(TPPTS)] had a rapid blood clearance (4.61 +/- 0.81 %ID/g at 5 min postinjection (p.i.) and 0.56 +/- 0.12 %ID/g at 120 min p.i.) and was excreted mainly via the renal route. [Tc-99m(HYNIC-tetramer)(tricine)(TPPTS)] had high tumor uptake with a long tumor retention (5.60 +/- 0.87 %ID/g and 7.30 +/- 1.32 %ID/g at 5 and 120 min p.i., respectively). The integrin alpha(v)beta(3)-specificity was demonstrated by co-injection of excess E[c(RGDfK)](2), which resulted in a significant reduction in tumor uptake of the radiotracer. The metabolic stability of [Tc-99m(HYNIC-tetramer)(tricine)(TPPTS)] was determined by analyzing urine and feces samples from the tumor-bearing mice at 120 min p.i. In the urine, about 20% of [Tc-99m(HYNIC-tetramer)(tricine)(TPPTS)] remained intact while only similar to 15% metabolized species was detected in feces. SPECT images displayed significant radiotracer localization in tumor with good contrast as early as 1 h p.i. The high tumor uptake and fast renal excretion make [Tc-99m(HYNIC-tetramer)(tricine)(TPPTS)] a promising radiotracer for noninvasive imaging of the integrin alpha(v)beta(3)-positive tumors by SPECT.
引用
收藏
页码:438 / 446
页数:9
相关论文
共 40 条
[1]  
ALBELDA SM, 1990, CANCER RES, V50, P6757
[2]  
Bögler O, 2003, CANCER J, V9, P205
[3]   Template assembled cyclopeptides as multimeric system for integrin targeting and endocytosis [J].
Boturyn, D ;
Coll, JL ;
Garanger, E ;
Favrot, MC ;
Dumy, P .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2004, 126 (18) :5730-5739
[4]   REQUIREMENT OF VASCULAR INTEGRIN ALPHA(V)BETA(3) FOR ANGIOGENESIS [J].
BROOKS, PC ;
CLARK, RAF ;
CHERESH, DA .
SCIENCE, 1994, 264 (5158) :569-571
[5]   Multimodality imaging of tumor integrin αvβ3 expression [J].
Chen, XY .
MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2006, 6 (02) :227-234
[6]   MicroPET imaging of breast cancer αv-integrin expression with 64Cu-labeled dimeric RGD peptides [J].
Chen, XY ;
Liu, S ;
Hou, YP ;
Tohme, M ;
Park, R ;
Bading, JR ;
Conti, PS .
MOLECULAR IMAGING AND BIOLOGY, 2004, 6 (05) :350-359
[7]   Molecular imaging of tumor angiogenesis [J].
Costouros, NG ;
Diehn, FE ;
Libutti, SK .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2002, :72-78
[8]   Improved targeting of the αvβ3 integrin by multimerisation of RGD peptides [J].
Dijkgraaf, Ingrid ;
Kruijtzer, John A. W. ;
Liu, Shuang ;
Soede, Annemieke C. ;
Oyen, Wim J. G. ;
Corstens, Frans H. M. ;
Liskamp, Rob M. J. ;
Boerman, Otto C. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 (02) :267-273
[9]   EXPRESSION OF BETA-1, BETA-3, BETA-4, AND BETA-5 INTEGRINS BY HUMAN LUNG-CARCINOMA CELLS OF DIFFERENT HISTOTYPES [J].
FALCIONI, R ;
CIMINO, L ;
GENTILESCHI, MP ;
DAGNANO, I ;
ZUPI, G ;
KENNEL, SJ ;
SACCHI, A .
EXPERIMENTAL CELL RESEARCH, 1994, 210 (01) :113-122
[10]  
FALCK J, 1994, SKOG FORSKNING, V1, P4